Although a Respiratory Syncytial Virus (RSV) infection usually manifests itself as a common cold, it can lead to serious bronchitis or pneumonia in young children.
Intensive medical care can help children to survive serious infections, but about 200,000 children throughout the world die annually from this infection. Unfortunately, there is no vaccine or precise treatment yet available to prevent or combat an RSV infection.
Related to the disease in calves
The human RSV is closely related genetically to a variant of the virus that occurs in calves with respiratory problems (BRSV). Because the progress of the infection is similar, calves are being studied to better understand the infection process and develop effective and safe intervention strategies.
Safe intervention strategies for RSV
The research on calves by Wageningen Bioveterinary Research (WBVR) contributes to the development and evaluation of vaccines and therapies for both children and calves. The resulting intervention strategies can help to reduce deaths and serious respiratory problems in people and animals worldwide.
Interested in our RSV model?
Please contact our expert to discuss the possibilities for contract research: